🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is studying the drugs called NeoVax (a new type of pers...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2022-01-03
Trial ID
NCT04930783
Treatments Being Tested
This research study is studying a novel type of CLL vaccine as a possible t...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2021-08-18
Trial ID
NCT03219450
Treatments Being Tested
This research study is evaluating a new type of vaccine called "Personalize...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2020-11-20
Trial ID
NCT04024878
Treatments Being Tested
This research study is evaluating a new type of melanoma vaccine called "Pe...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2014-04
Trial ID
NCT01970358
This is a single institution, open-label, multi-arm, pilot study assessing ...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2018-10-31
Trial ID
NCT03422094
Treatments Being Tested
This research study is investigating a new type of personalized neoantigen ...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2020-11-11
Trial ID
NCT03929029
Treatments Being Tested
This research study is evaluating a new type of Kidney Cancer vaccine calle...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2019-03-03
Trial ID
NCT02950766
Treatments Being Tested
This research study is studying a new type of vaccine as a possible treatme...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2014-11
Trial ID
NCT02287428
This research study is studying a novel type of FL vaccine as a possible tr...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2022-03-14
Trial ID
NCT03361852
Treatments Being Tested
This is a phase I, open-label, single-arm, single-center, dose-escalation s...
Status
Recruiting
Location
West China Hospital
Start Date
2026-04-28
Trial ID
NCT07560943
Treatments Being Tested